Management of Low-Grade Gliomas

R. Soffietti, B. Baumert, L. Bello, A. Von Deimling, H. Duffau, M. Frénay, W. Grisold, R. Grant, F. Graus, K. Hoang-Xuan, M. Klein, B. Melin, J. Rees, T. Siegal, A. Smits, R. Stupp, W. Wick

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

Original languageEnglish
Title of host publicationEuropean Handbook of Neurological Management
Number of pages11
Publication statusPublished - 21 Sept 2011


  • Antiepileptic treatment-no papers dealing with antiepileptic drugs (AEDs), with LGG and seizures
  • Chemotherapy (PCV or TMZ), initial treatment after surgery-in high-risk patents
  • Cognitive rehabilitation, salutary effect-on short- and long-term cognitive complaints and mental fatigue
  • Conventional MRI, for differential diagnosis-biopsy or resection
  • Low-grade gliomas (LGGs)-group of tumours, clinical, and molecular characteristics
  • Management of low-grade gliomas
  • Oligoastrocytomas, on detection-convincing astrocytic and oligodendroglial components
  • Oligodendrogliomas, cellular-perinuclear halos ('fried egg' or 'honeycomb'pattern)
  • Seizures, common presentation-partial or generalized
  • World Health Organization (WHO) classification-grade II astrocytomas, oligodendrogliomas and oligoastrocytomas (Class I)

Cite this